Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brenda F Kurland

Showing results (1-10 of 91) with videos related to

Pageof 10
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Heterogeneity in Metastatic Breast Cancer <sup>18</sup>F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?Brenda F Kurland, Steffi Oesterreich
American Journal of Epidemiology|November 25, 2003
Prognostic effect of prior disability episodes among nondisabled community-living older personsThomas M Gill, Brenda F Kurland
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of NonresponseBrenda F Kurland, Brian L Egleston
Statistics in Medicine|August 19, 2004
Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-outBrenda F Kurland, Patrick J Heagerty
Biostatistics (Oxford, England)|March 18, 2005
Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deathsBrenda F Kurland, Patrick J Heagerty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
FDG PET and FES PET Predict PFS on Endocrine Therapy-ResponseBrenda F Kurland, Hannah M Linden, David A Mankoff
Current Opinion in Supportive and Palliative Care|October 9, 2012
Accommodation of missing data in supportive and palliative care clinical trialsBrenda F Kurland, Laura L Johnson, Paula H Diehr
Gynecologic Oncology|June 10, 2008
Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology ConsortiumBarbara A Goff, Leona A Holmberg, Dan Veljovich, et al.
JAMA Psychiatry|June 15, 2018
Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical TrialSaul Shiffman, Brenda F Kurland, Sarah M Scholl, et al.
Psychopharmacology|October 7, 2018
Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?Saul Shiffman, Jason M Mao, Brenda F Kurland, et al.
Pageof 10

Showing results (1-10 of 91) with videos related to

Sort By:
Pageof 10
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Heterogeneity in Metastatic Breast Cancer <sup>18</sup>F-Fluoroestradiol Uptake: Clinically Actionable, Biologically Illuminating?Brenda F Kurland, Steffi Oesterreich
American Journal of Epidemiology|November 25, 2003
Prognostic effect of prior disability episodes among nondisabled community-living older personsThomas M Gill, Brenda F Kurland
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 8, 2016
For Health-Related Quality of Life and Other Longitudinal Data, Analysis Should Distinguish Between Truncation by Death and Data Missing Because of NonresponseBrenda F Kurland, Brian L Egleston
Statistics in Medicine|August 19, 2004
Marginalized transition models for longitudinal binary data with ignorable and non-ignorable drop-outBrenda F Kurland, Patrick J Heagerty
Biostatistics (Oxford, England)|March 18, 2005
Directly parameterized regression conditioning on being alive: analysis of longitudinal data truncated by deathsBrenda F Kurland, Patrick J Heagerty
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 5, 2017
FDG PET and FES PET Predict PFS on Endocrine Therapy-ResponseBrenda F Kurland, Hannah M Linden, David A Mankoff
Current Opinion in Supportive and Palliative Care|October 9, 2012
Accommodation of missing data in supportive and palliative care clinical trialsBrenda F Kurland, Laura L Johnson, Paula H Diehr
Gynecologic Oncology|June 10, 2008
Treatment of recurrent or persistent platinum-refractory ovarian, fallopian tube or primary peritoneal cancer with gemcitabine and topotecan: a phase II trial of the Puget Sound Oncology ConsortiumBarbara A Goff, Leona A Holmberg, Dan Veljovich, et al.
JAMA Psychiatry|June 15, 2018
Nondaily Smokers' Changes in Cigarette Consumption With Very Low-Nicotine-Content Cigarettes: A Randomized Double-blind Clinical TrialSaul Shiffman, Brenda F Kurland, Sarah M Scholl, et al.
Psychopharmacology|October 7, 2018
Do non-daily smokers compensate for reduced cigarette consumption when smoking very-low-nicotine-content cigarettes?Saul Shiffman, Jason M Mao, Brenda F Kurland, et al.
Pageof 10